Lombard Odier & Cie (Bahamas)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$89K Hold
1,500
0.03% 56
2015
Q2
$100K Hold
1,500
0.04% 60
2015
Q1
$97K Sell
1,500
-1,200
-44% -$75.1K 0.04% 59
2014
Q4
$159K Hold
2,700
0.06% 58
2014
Q3
$138K Hold
2,700
0.05% 61
2014
Q2
$131K Hold
2,700
0.05% 74
2014
Q1
$140K Hold
2,700
0.06% 71
2013
Q4
$144K Buy
+2,700
New +$138K 0.06% 79

Other funds holding BMY

Lombard Odier & Cie (Bahamas)'s BMY Position: Q3 2015 in Review

Lombard Odier & Cie (Bahamas) held its Bristol-Myers Squibb (BMY) position steady in Q3 2015 at 1,500 shares worth $89K. The position accounts for 0.03% of the portfolio, ranked #56.

Lombard Odier & Cie (Bahamas) first reported a position in BMY in Q4 2013 and has held it in 8 quarters since. The position peaked at $159K in Q4 2014. 1,454 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

  • Lombard Odier & Cie (Bahamas) held 1,500 shares of Bristol-Myers Squibb worth $89K as of Q3 2015.
  • Lombard Odier & Cie (Bahamas) left its Bristol-Myers Squibb share count unchanged in Q3 2015.
  • Bristol-Myers Squibb made up 0.03% of Lombard Odier & Cie (Bahamas)'s portfolio in Q3 2015, its #56 holding.
  • Lombard Odier & Cie (Bahamas) first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 8 quarters since.
  • Lombard Odier & Cie (Bahamas)'s Bristol-Myers Squibb position peaked at $159K in Q4 2014.
  • 1,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on Lombard Odier & Cie (Bahamas)'s 13F filing for Q3 2015, filed 13 Nov 2015.